tiprankstipranks
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market

Compare Mabpharm Limited (2181) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Mabpharm Limited
HK$0.50
HK$1.92B
33.28
-6.06%
Antengene Corporation Limited
HK$5.27
HK$3.56B
-9.15
130.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.76B
-16.66
185.88%
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
HK$5.71
HK$1.07B
-18.55
119.00%
SinoMab Bioscience Ltd.
HK$1.39
HK$2.24B
-14.44
44.25%
Immunotech Biopharm Ltd
HK$2.68
HK$2.16B
-6.43
4.32%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2181
Mabpharm Limited
0.47
-0.01
-3.12%
HK:6996
Antengene Corporation Limited
5.61
2.88
105.49%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.86
3.23
198.16%
HK:2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
4.38
2.23
103.72%
HK:3681
SinoMab Bioscience Ltd.
1.63
0.48
41.74%
HK:6978
Immunotech Biopharm Ltd
3.50
-0.24
-6.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts